Carlsmed, Inc. (CARL)

Carlsmed Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-24.54	-24.85	-18.9
Depreciation & Amortization	0.15	0.15	0.14
Share-Based Compensation	-	0.25	0.12
Other Operating Activities	-1.81	-1.61	1.17
Operating Cash Flow	-26.21	-25.47	-17.48
Capital Expenditures	-0.37	-0.18	-0.14
Investing Cash Flow	-0.37	-0.18	-0.14
Share Issuance / Repurchase	-	52.29	0.06
Debt Issued / Paid	-	6.21	3.13
Financing Cash Flow	31.7	58.5	3.18
Net Cash Flow	5.13	32.85	-14.44
Free Cash Flow	-26.58	-25.65	-17.62
Free Cash Flow Margin	-82.36%	-94.41%	-127.85%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).